Biology42: Generative Biologics

Platform

AI platform for de novo design and multi-property optimization of peptides, nanobodies and antibodies against specified targets and epitopes.

Find alternatives to Biology42: Generative Biologics

TypePlatform
RoleStandalone tool
AvailabilitySold
DeploymentSaaS
Intended for—
SecurityNot recorded
StatusActive
Sold withinSold on its ownOfficial documentation · 15 Sep 2026
Sources1 of 1 field

No price disclosed; page directs to email or a Calendly consultation. No pricing page for this product in the sitemap.

What it does

pharma.ai

Sources

Pricing

Official documentation · 3 Sep 2026

Contact-and-consultation model only. Page's own heading is 'Biology42: Generative Biologics'; suite nav shortens this to 'Generative Biologics'.

Sold within

Official documentation · 15 Sep 2026

pharma.ai/generativebiologics (already cited official-docs elsewhere on this record); standalone technology access or combined with Pharma.ai collaborations, no restriction.

Also from Insilico Medicine

Open Insilico Medicine in the directory

Something wrong here? Send a correction — quote this product id: insilico-medicine-generative-biologics.